Micro Laboratories Products Found to Reduce Withdrawls Symptoms During Quit Smoking Clinical Trials

Johnston RI. February draft 2003.... Micro Laboratories, Inc, (OTCBB;MLAR) announced results of a study performed by Bruce Becker, MD, Beth Bock PhD, and Rosa Carmona-Barros MS. of The Centers for Behavorial and Preventive Medicine. The Miriam Hospital, Rhode Island Hospital and Brown Medical School. The study found that one of Micro Baboratories products help to reduce withdrawl symptoms durring quitting smoking clinic trials.

Dr. Becker will be presenting a paper entitled "ST. John's Wort Oral spray Reduces Withdrawl Symptoms During Quitting Smoking" on February 22 at the Society for Research on Nicotine and Tabacco's 9th annual Scientfic Session being held at the Sheraton New Orleans Hotel. (www.srnt.org)

The study tested the effect of St. John's Wort, a natural herbal preperation, on smoking withdrawl systems. St. John's Wort was delivered to the patient in a unique oral spray formulation which could be used muliple times per day by the subject, mirroring the subjects pattern of cigarette smoking. ST. John's Wort decreased subjects anxiety, sleepness, and restlessess during the first few days after quitting and their cravings for cigarettes and irritability throughout the 2 weeks study period.

Robert Thistle, CEO of Micro Laboratories, stated, "We are pleased that this study affirms our belief that oral spray delivery of certain medications can provide a very real benefit. This expands the validity of our spray vitamin products".

About Micro Laboratories, Inc:
Micro Laboratories, Inc. is a specialist in the design and manufacture of Micro Spray, vitamins, anti-depressant and oral breath sprays. Micro Spray products also has a patented formula for the prevention of halitosis and tooth decay.

Micro Spray is fully developed and offers a 90% absorption rate higher then products administered by pill. The Micro Spray delivery system is sprayed directly under the tongue or the inside of the cheek in a fine mist. Micro Spray is absorbed into the bloodsteam and assimilated throughout the body.

This press release includes forward looking statements. These statements are made pursant to the safe harbor provisions of the Private Securties Litigation Reform Act of 1995. Inherent risks and uncertainies could cause qactual results to differ materially from the forward-looking statements. Such risks and uncertainties are described in the periodic reports the Company files with the Security and Exchange Commission. The Company under takes no obligation to update these statements for revisions or changes after the date of this release.

For more information on Micro Laboratories or to purchase Micro Spray products, please contact:

Robert Thistle, CEO, Micro Laboratories, Inc Johnston, RI (800)555-1276
or media: for detailed information or to arrange interviews with Dr. Breck please contact Robert Schechter, Equity Communications, 212-499-6809.